Document Type : Original Research Article


Department of Chemistry, College of Science, Baghdad University, Baghdad, Iraq


This work focused on the synthesis of C-glycoside that contained thiouracil unite, which were synthesized from glucon-2-carbothioate thiouracil derivatives [C1-C4] via reaction of gluconic acid, thionyl chloride, and thiouracil derivatives in a one-pot reaction in the presence of triethylamine as a catalyst. Furthermore, we performed synthesis of 2-(glucofuranose) thiouracil derivatives [C5, C6] via condensation reaction of D- glucurone, ethyl cyanoacetate, and thiourea or phenyl thiourea in presence of potassium carbonate, and studying the possibility for their application as antifungal, antibacterial, and antioxidant.

Graphical Abstract

Synthesis of C- glycoside analogs containing thiouracil derivatives and evaluated as antibacterial, antifungal and antioxidant activities


Main Subjects



The metabolic stability of these compounds finds application in the inhibition of carbohydrate processing enzymes [1], C-glycosides being able to fit into the active site of glycosidases and glycosyltransferases without being modified by the enzyme. This behavior also allows mapping the active site to study the recognition and binding processes [2], and to investigate the mechanism of action of these enzymes. The metabolic stability of C-glycosides is also exploited in the generation [3] of glycomimetic drugs resistant to in vivo hydrolysis [4], such as integrin ligands or glycemic immunostimulators [5]. Those compounds showed a variety of interesting biological properties such as antitumor, antiviral, or antibacterial activities. The combination of metabolic stability and relevant biological activities generated a great interest in the synthesis of a variety of C-glycosides designed to inhibit specific enzymes, act as agonists or anti-agonists in precentral phenomena, and induce an immunogenic response. Aryl C-glycosides, in particular anthraquinone-carbohydrate hybrids such as undamynone B8, have shown DNA-binding properties and cytotoxicity [6]; therefore, they can be promising antitumor agents. C-Glycosides presenting reactive α-Bromo ketone functionality have been described as irreversible inhibitors of glycosi-dases. More sophisticated C-glycosidic structures have been synthesized to mimic NDP-sugars, hence act as specific inhibitors of glycosyltransferases. C-Glycosides related to tumor-associated antigens are another relevant synthetic target [7]. Mimics of GalNAca1-O-Ser (Tn antigen) linked to immunogenic peptides to elicit both B- and T-immune responses have been synthesized [8]. To achieve increased stability, ligation has been applied to the site-specific attachment of the sugar moiety. Chemo selectivity was obtained by coupling a thiouracil group. It is well known that thiouracil derivatives are of great [9,10] biological attention, especially as Anti-HIV, antimicrobial [11], anti-inflammatory [12], and antitumor agents [13,14].



Melting points have been registered using the melting point equipment of the Gallen Kamp hot stage and adjusted. Fourier Transform Infrarouge Species SHIMADZU (8300) infrarouge, Japan, in range (4000-600) cm-1 were used to record spectra of infrarot transform in the Fourier Transform spectrometer SHIMADZU (8300), Japan. Tetramethyl saline as internal standard and DMSO-d6 as a solvent were recorded using Bruker, Ultrasheild (500) MHz nuclear magnetic resonance (Germany).


Synthesis of S-(thiouracil derivatives) gluconthioate [C1-C4].[15]

Gluconic acid (0.001 mol) was added to 0.001 mol of thiouracil derivatives and 3 mL of triethylamine in dimethylformamide, then (0.001 mol) of SOCl2 was added at 0 °C in one pot. The mixture was stirred for 5–20 minutes at 25 °C, then the mixture was refluxed for 2hrs. The resulting product was washed with 1 N HCl and then with 1 N NaOH. The organic phase was dried by (Na2SO4) and evaporated to dryness to produce compounds [C1-C4].

Compound [C1]: Yield was (73%), with mp: (166–169 °C), Rf: (0.27), IR, (cm-1): 3453 (OH), 3126 (NH), 2929 (CH), 1654 (C=O) thiol, 1629(C=O) amide.

Compound [C2]: Yield was (66%), with mp: (234-235 °C), Rf: (0.35), IR, (cm-1): 3448 (OH), 3161 (NH), 2212 (CN), 1676 (C=O) thiol, 1625 (C=O) amide.

Compound [C3]: Yield was (63%), with mp: (254-256 °C), Rf: (0.27), IR, (cm-1): 3431 (OH), 3058 (NH), 2275 (CN), 1642 (C=O) thiol, 1610 (C=O) amide, 1519, 1317 sym., asym. (NO2). 1H NMR (DMSO-d6): 3.25- 3.78 (m,5H, Sugar protons); 4.21- 4.86 (s,4H, OH); 7.90-8.05 (m,4 H, Ar-H); 12.01 (S,1H, NH). 13C NMR: 67.34 -98.06 (5C, CH of sugar) 94.16(1C, CH of sugar); 112.09 (CN); 127.06 -131.46(4C, CH aromatic); 160.13 (C=N); 168.69 (N-C=O); 197.38 (S-C=O).

Compound [C4]: Yield: (66%), mp: (178-181 °C), IR, (cm-1): 3446 (OH), 3197 (NH), 2200 (CN), 1649 (C=O) thiol, 1598 (C=O) amide.1H NMR (DMSO-d6): 1.90- 3.53 (s,6H, OCH3); 3.35- 3.99 (m,5H, Sugar protons); 4.45- 4.56 (s,4H, OH); 6.27- 6.57 (m,4 H, Ar-H); 8.15 (S,1H, NH). 13C NMR: 72.33 -90.02 (5C, CH of sugar) 94.68 (1C, CH of sugar); 113.04 (CN); 111.069-134.12 (4C, CH aromatic); 163.16 (C=N); 164.89 (N-C=O); 194.92(S-C=O).

Synthesis of 6-(Gluco) thiouracil derivatives [C5, C6]:[16]

A mixture of the D-glucurone (0.01 mol), ethyl cyanoacetate (0.01 mol), thiourea or phenyl thiourea (0.01 mol), and potassium carbonate (0.01 mol), in 30 mL ethanol, was heated for 12 h under reflux. On cooling, the separated precipitate was filtered, washed with ether, and dried. The obtained solid was added to water (20 mL), and the mixture was heated at 80–90 °C until a clear solution was obtained. After cooling, the solution was acidified with acetic acid, and stirring was continued for 30 min. The deposited precipitate was filtered, washed with cold water, dried, and crystallized from ethanol to produce compounds [C5, C6].

Compound [C5]: Yield was (77%), mp: (66-68 °C), IR, (cm-1): 3433 (OH), 3255 (NH), 2244 (CN), 1604 (C=O) amide. 1 H NMR (DMSO-d6): 1.98, 2.08 (d,2H, CH2) 3.20- 3.41 (m,5H, Sugar protons); 4.37- 4.81 (s,4H, OH); 8.53, 12.76 (S,2H, NH). 13C NMR: 67.34 -98.06 (5C, CH of sugar) 94.16(1C, CH of sugar); 112.09 (CN); 127.06 -131.46(4C, CH aromatic); 160.13 (C=N); 168.69 (N-C=O); 197.38 (S-C=O).

Compound [C6]: Yield was (75%), mp: (98-101 °C), Rf: (0.24), IR, (cm-1): 3423 (OH), 3182 (NH), 3082 (Ar-CH), 2124 (CN), 1612 (C=O).

Assessment of biological activity

Antibacterial and antifungal activities

Biological activity of some new free C- glycoside analogs were tested in vitro for two Gram-positive microbes (Staphylococcus aureus, Bacillus subtilis), three Gram-negative microbes (Pseudomonas Aeuroginosa, Escherichia Coli, Klebsiella pneumoniae), and fungi (Macrosporium) with concentration (0.025 g/mL) using conventional cup-plate agar diffusion method [17]. The inhibitory zone for the spread of microorganisms on the platform incorporates this way of communication. The results were shown as the average diameter of bacterial or fungal growth in inhibition zones about mm for every investigated drug [18].

Antioxidant activity

The scavenging measurements of some synthesis compounds were estimated using a constant DPPH assay for determining the IC50 values. Using three unlike concentrations (10, 5, and 2.5 µg/mL) of each compound. The absorbance was measured at 517 nm for each compound [19,20]. The antioxidant activity of the compounds was compared with ascorbic acid as standard.

Results and discussion


C-glycosides were accessed by two methods. First method was via reaction of gluconic acid, thionyl chloride, and thiouracil derivatives in one-pot reaction in the present of triethylamine as catalysis as shown in Equation (3.1).

The second method was via condensation reaction of D-glucurone, ethyl cyanoacetate, thiourea or phenyl thiourea, and potassium carbonate is shown in Equation (3.2).

Some new compounds were fully characterized by spectroscopic analysis (IR, 1H NMR, and 13CNMR). The results are consistent with the proposed structures.

Biological assessment

Antibacterial and antifungal activities

Compounds [C1, C4, C6] have been tested as an antimicrobial agent for two types of Gram-positive bacteria, three types of Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia) and yeast-like pathogenic fungi, against a panel of standard pathogenic strains Compounds [C1, C4, C6] (Macrosporium). The screening was performed with the agar disc diagram. The chemicals examined showed considerable action with the antibiotic and antifungal medicines of broad scope. Compound [C1] shows high effectiveness compared with control for all types of bacteria and fungi. Compound [C4] shows high effectiveness compared with control for all types of bacteria and fungi except Pseudomonas aeruginosa does not give inhibition. All results are shown in Table 1.

Antioxidant active

The newly synthesized compounds showed antioxidant activity against DPPH free radicals and gave a good scavenging percentage. So, the compounds that were tested illustrated antioxidant properties were selected for further testing. Accordingly, inhibitory concentrations (IC50) values were recorded and tabulated in Table 2; accordingly, we applied the anti-oxidant activity classification which depends on IC50 range values published by Phongpaichi [21]. See Table 3 for more details about these ranges. So, all the prepared compounds are considered to be of good activity because the IC50 value is relatively low.


In conclusion, new selective C-glycosides continuing thiouracil derivatives were synthesized in good yields. The new C-glycosides formed were structurally characterized and tested for biological activity against fungi and bacteria species and antioxidant activities. Some of the tested products showed good and moderate activity and the results were reported.


We thank Prof. Dr. Mohammed Rifat. Ahamad

for his valuable scientific information. I also thank the Ministry of Higher Education and Scientific Research, the University of Baghdad, and the College of Science.


Taghreed S. Hussein:

How to cite this article: Taghreed S. Hussein*, Mohammed R. Ahamad. Synthesis of C- glycoside analogs containing thiouracil derivatives and evaluated as antibacterial, antifungal and antioxidant activities. Eurasian Chemical Communications, 2021, 3(8), 584-589. Link:

Copyright © 2021 by SPC (Sami Publishing Company) + is an open access article distributed under the Creative Commons Attribution License(CC BY)  license  (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

[1] G.J. Davies, M. Dauter, A.M. Brzozowski, M.E. Bjørnvad, K.V. Andersen, M. Schülein, Biochemistry, 1998, 37, 1926-1932. [crossref], [Google Scholar], [Publisher]‏    
[2] W. Pan, C. Ansiaux, S.P. Vincent, Tetrahedron Lett., 2007, 48, 4353-4356. [crossref], [Google Scholar], [Publisher]‏  
[3] S. El Bkassiny, I.S. N’Go, C.M. Sevrain, A. Tikad, S.P. Vincent, Org. Lett., 2014, 16, 2462-2465. [crossref], [Google Scholar], [Publisher]‏   
[4] A. Pałasz, D. Cież, B. Trzewik, K. Miszczak, G. Tynor, B. Bazan, Top. Curr. Chem., 2019, 377, 1-84. [crossref], [Google Scholar], [Publisher]‏    
[5] A. Caravano, D. Baillieul, C. Ansiaux, W. Pan, J. Kovensky, P. Sinaÿ, S.P. Vincent, Tetrahedron, 2007, 63, 2070-2077. [crossref], [Google Scholar], [Publisher]‏    
[6] T. Bililign, B.R. Griffith, J.S. Thorson, Nat. Prod. Rep., 2005, 22, 742-760. [crossref], [Google Scholar], [Publisher]‏    
[7] P.M. Foley, A. Phimphachanh, E.S. Beach, J.B. Zimmerman, P.T. Anastas, Green Chem., 2011, 13, 321-325. [crossref], [Google Scholar], [Publisher]‏    
[8] S. Yuan, S. Yin, M. Liu, J.-Q. Kong, Scientific reports, 2018, 8, 1-13. [crossref], [Google Scholar], [Publisher]‏    
[9] E. Abdelghani, S.A. Said, M. Assy, A.M.A. Hamid,         J. Iran. Chem. Soc., 2015, 12, 1809-1817. [crossref], [Google Scholar], [Publisher]‏    
[10]  (a) G. Waghmare, S. Junne, S. Shinde, A. Waghamare, S. Kuberkar, Chem Sci Trans., 2013, 2, 1-4. [crossref], [Google Scholar], [Publisher]‏     (b)         V.A. Adole, J. Appl. Organomet. Chem., 2021, 1, 29-40. [crossref], [Google Scholar], [Publisher]‏  (c) S.B Biradar, D.V. Narte, R.P. Kale, K.I. Momin, M.S. Sudewad, K.C. Tayade, D.G. Palke, J. Appl. Organomet. Chem., 2021, 1, 41-47. [crossref], [Google Scholar], [Publisher]‏
[11] C. Mugnaini, F. Manetti, J.A. Esté, I. Clotet-Codina, G. Maga, R. Cancio, M. Botta, F. Corelli,  Bioorg. Med. Chem. Lett., 2006, 16, 3541-3544. [crossref], [Google Scholar], [Publisher]‏
[12] D.J.L. BAI, Int. J. Inv. Pharm. Sci., 2014, 2, 759-766. [Pdf], [Google Scholar], [Publisher]‏
[13] X. Zhang, X. Zhou, R.L. Kisliuk, J. Piraino, V. Cody, A. Gangjee, Bioorg. Med. Chem., 2011, 19, 3585-3594. [crossref], [Google Scholar], [Publisher]‏
[14] N. Sekhar, P.V. Acharyulu, Y. Anjaneyulu, Tetrahedron Lett., 2011, 52, 4140-4144. [crossref], [Google Scholar], [Publisher]‏
[15] (a) A. Leggio, E. Belsito, G. De Luca, M. Di Gioia, V. Leotta, E. Romio, C. Siciliano, A. Liguori, Rsc Advances, 2016, 6, 34468-34475. [crossref], [Google Scholar], [Publisher]‏
(b) M.V.  Gaikwad, J. Appl. Organomet. Chem., 2021, 1, 59-65. [crossref], [Google Scholar], [Publisher]‏
[16] M.A. Al-Omar, A.R.M. Al-Obaid, N.R. El-Brollosy, A.A. El-Emam, Synth. Commun., 2010, 40, 1530-1538. [crossref], [Google Scholar], [Publisher]‏
[17] R.W. Franck, Comptes Rendus Chimie, 2012, 15, 46-56. [crossref], [Google Scholar], [Publisher]‏
[18] R. Kalkotwar, R. Saudagar, Asian J. Pharm. Res., 2013, 3, 159-165. [Google Scholar], [Publisher]‏
[19] M. Jabir, U.I. Sahib, Z. Taqi, A. Taha, G. Sulaiman, S. Albukhaty, A. Al-Shammari, M. Alwahibi, D. Soliman, Y.H. Dewir, H. Rizwana, Int. J. Nanomedicine, 2020, 15, 9025. [crossref], [Google Scholar], [Publisher]‏    
[20] S. Al-Musawi, S. Albukhaty, H. Al-Karagoly, G.M. Sulaiman, M.S. Jabir, H. Naderi-Manesh, Adv. Nat. Sci.: Nanosci. Nanotechnol., 2020, 11, 045009. [crossref], [Google Scholar], [Publisher]‏    
[21] N. Jadid, D. Hidayati, S.R. Hartanti, B.A. Arraniry, R.Y. Rachman, W. Wikanta, AIP Conference Proceedings 1854, 2017, 020019. [crossref], [Google Scholar], [Publisher]‏